On ECHEMI
Home > Drugs > Renal medullary necrosis
Renal medullary necrosis
Renal medullary necrosis is also known as renal papillary necrosis (RPN) and necrotizing papillitis. Its essence is ischemic necrosis of the renal papilla and its adjacent renal medulla. This disease can occur in a variety of diseases, mainly those that cause chronic tubulointerstitial nephropathy. In these chronic tubulointerstitial nephropathy, the lesions of the medullary band in the kidney are often more serious. Its basic lesion is impaired renal blood circulation, causing localized or diffuse ischemic necrosis of the distal end of one or more renal pyramids.
  • Site of disease:

    kidney
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Chills diabetes insipidus polyuria high fever hypoxemia
  • Concurrent disease:

Related Drugs
Dipyridamole
Indication: This product was once a commonly used drug for the treatment of coronary heart disease, but is now rarely used to prevent myocardial ischemia. Its antiplatelet aggregation effect can be used in heart surgery or valve replacement surgery to reduce the formation of thromboembolism.
Manufacturer:

Shanxi Shuangyan Pharmaceutical Co., Ltd.

Peritoneal dialysis fluid (lactate-G4.25%)
Indication: 1. Acute renal failure. 2. Chronic renal failure. 3. Acute drug or poisoning. 4. Refractory heart failure. 5. Refractory edema. 6. Electrolyte imbalance and acid-base imbalance.
Manufacturer:

Shanghai Changzheng Fumin Jinshan Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.